The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
Open accessAbstract
To study exogenous fat metabolism, we used the vitamin A-fat loading test, which specifically labels intestinally derived lipoproteins with retinyl palmitate (RP). Postprandial RP concentrations were followed in total plasma, and chylomicron (Sf greater than 1,000) and nonchylomicron (Sf less than 1,000) fractions. In normal subjects postprandial lipoproteins were present for more than 14 h, and chylomicron levels correlated inversely with lipoprotein lipase activity and fasting high density lipoprotein (HDL) cholesterol levels and nonchylomicron levels correlated inversely with hepatic triglyceride lipase activity. The main abnormality in type IV patients was a 5.6-fold increase in the chylomicron fraction, whereas in type III patients it was a 6.4-fold increase in nonchylomicrons. Type IIa patients had abnormally low chylomicron fractions. In type IV patients gemfibrozil decreased, whereas in type IIa patients cholestyramine increased the chylomicron fraction 66 and 88%, respectively. This study demonstrates an unexpectedly large magnitude and long duration of postprandial lipemia in normal subjects and patients. These particles are potentially atherogenic, and their role in human atherosclerosis warrants further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased concentrations of circulating chylomicron-remnant particles are then preferentially taken up by the liver by means of a receptor-mediated process,18–22 resulting in non-alcoholic fatty liver disease and hepatic insulin resistance.”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,154
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212
Self-citationCLEARING FACTOR, A HEPARIN-ACTIVATED LIPOPROTEIN LIPASE
Korn, E. D. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66011-9 · Cited by 858
The Familial Hyperlipoproteinemias
Marion, M. S. (1975) · Cited by 528
Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons
Redgrave, T. G. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106255 · Cited by 498
Krauss, R. M., Levy, R. I., & Fredrickson, D. S. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107855 · Cited by 436
Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.
Jh, B., Levitt, & Prentiss, R. A. (1975) · PubMed · Cited by 416
Patsch, J. R., Karlin, J. B., Scott, L. W., Smith, L. C., & Gotto, A. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1449 · Cited by 386
Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
Hui, D. Y., Innerarity, T. L., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69254-9 · Cited by 383
Flagged first, then by citations
Research works printed but not linked: 4
- [10]10. Redgrave, T. G. 1984. Postprandial remnants and their relation to atherosclerosis. In Latent Dyslipoproteinemias and Atherosclerosis. J. L. DeGennes, J. Polonovski, and R. Paoletti, editors. Raven Press, New York. 9–15.
- [25]25. Lindgren, F. T., L. C. Jensen, and F. T. Hatch. 1972. The isolation and quantitative analysis of serum lipoproteins in blood lipids and lipoproteins. In Quantitation, Composition and Metabolism. G. S. Nelson, editor. Wiley Interscience, New York. 181–274.
- [31]31. Schoefe, G. I., and J. E. French. 1968. Vascular permeability to pdats e mo pams amay gland and of lung. Proc. R. Soc. (Biol.). 169:153–165.
- [46]46. Ehnholm, C., R. W. Mahley, D. A. Chappel, K. H. Weisgraber, E. Ludwig, and J. L. Witztum. 1984. Role of apolipoprotein E in the ipon l lw in o po lnsiy lipoproteins in type III hyperlipoproteinemia. Proc. Natl. Acad. Sci. USA. 81:5566-5570.
Cited by
Sorted by citations
Items 201–261 of 261
Fibrates and triglyceride metabolism
SCHWANDT, P. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf01409407 · Cited by 13
Postprandial Retinyl Palmitate and Squalene Metabolism Is Age Dependent
Relas, H., Gylling, H. K., Rajaratnam, R., & Miettinen, T. A. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.11.b515 · Cited by 12
The direct way from gut to vessel wall: Atheroinitiation
Cabezas, C., & Erkelens (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00318.x · Cited by 11
Austin, G., Ferguson, J. J. A., Thota, R. N., Singh, H., Burrows, T. L., & Garg, M. L. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.06.027 · Cited by 11
Kinoshita, M., Kawamura, M., Fujita, M., Hirota, D., Suda, T., Taki, M., Kusano, J., Takao, K., Takenaka, H., Kubota, S., et al. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.167 · Cited by 11
Juhel, C., Pafumi, Y., Senft, M., Lafont, H., & Lairon, D. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500000696 · Cited by 11
Bradley, W. A., Booyse, F. M., & Gianturco, S. H. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90151-1 · Cited by 11
Hoffmann, M. M., Jacob, S., Luft, D., Schmülling, R.-M., Kristian, R. E. T. T., März, W., Häring, H., & Matthaei, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7069 · Cited by 11
Benefits and hazards of dietary carbohydrate
Connor, W. E., Duell, P. B., & Connor, S. L. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0059-4 · Cited by 11
Lipid disorders contributing to coronary heart disease: An update
Superko, H. R. (1996) · Current Problems in Cardiology · doi:10.1016/s0146-2806(96)80005-3 · Cited by 10
The genetic determinants of plasma cholesterol and response to diet
Humphries, S. E., Peacock, R. E., & Talmud, P. J. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80161-8 · Cited by 10
Iaina, A., Silverberg, D. S., Wolman, Y., JUDEVICS, R., Baruch, R., LEVHAR, C., Peer, G., Blum, M. S., Grosskopf, I., & Weintraub, M. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00188-h · Cited by 10
Self-citationApolipoprotein genes and atherosclerosis
Breslow, J. L. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00235516 · Cited by 10
Self-citationHypercholesterolemia and dyslipidemia
Superko, H. R. (2000) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-000-0010-5 · Cited by 10
Sternak, M., Stojak, M., Banasik, T., Kij, A., Bar, A., Pacia, M. Z., Wojnar‐Lason, K., Chorazy, N., Mohaissen, T., Marczyk, B., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05167-6 · Cited by 9
Daher, C. F., Slaiby, R., Haddad, N. E., Boustany, K. C., & Baroody, G. M. (2006) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390500362279 · Cited by 9
Föger, B., Tröbinger, G., Ritsch, A., Lechleitner, M., Hopferwieser, T., Menzel, H., Utermann, G., Pfeiffer, K. P., & Patsch, J. R. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05580-p · Cited by 9
Sijbrands, E. J. G., Westendorp, R. G. J., Hoffer, M. J. V., Frants, R. R., Meinders, A. E., Souverijn, J. H. M., Leuven, J. A. G., van der Laarse, A., Havekes, L. M., & Smelt, A. H. M. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05901-1 · Cited by 9
Postprandial lipemia in patients with coronary artery disease
Patsch, J. R., Hopferwieser, T., Patsch, W., Drexel, H., Mühlberger, V., Knapp, E., & Braunsteiner, H. (1990) · Springer eBooks · doi:10.1007/978-94-009-0731-7_40 · Cited by 9
Weber, P. A., Schrezenmeir, J., Fenselau, S., Ausieker, S., Probst, R., ZUCHHOLD, H. D., Prellwitz, W., & Beyer, J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35722.x · Cited by 9
Gylling, H., & Miettinen, T. A. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00778.x · Cited by 9
Therapeutic considerations for postprandial dyslipidaemia
Burnett, J. R., & Watts, G. F. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00155.x · Cited by 8
DITSCHUNEIT, H. H., Flechtner‐Mors, M., Hagel, E., & DITSCHUNEIT, H. H. (1992) · Journal of International Medical Research · doi:10.1177/030006059202000301 · Cited by 8
Isherwood, S. G., Williams, C. M., & GOULD, B. J. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970050 · Cited by 7
The hypolipidemic activity of heterocyclic amine boranes in rodents
HALL, I. H., Sood, A., & Spielvoge, B. (1991) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(91)90062-x · Cited by 8
Effect of Gemfibrozil Administration on Biliary Lipid Secretion in Hyperlipidemic Patients
Mazzella, G., Bazzoli, F., Villanova, N., Simoni, P., Festi, D., Roda, A., Aldini, R., & Roda, E. (1990) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529008998558 · Cited by 8
Daher, C. F., Berberi, R., & Baroody, G. M. (2003) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(03)00172-8 · Cited by 7
Noutsou, M., & Georgopoulos, A. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(99)00036-7 · Cited by 7
Gastrointestinal Responses to Dietary Fiber
Schneeman, B. O. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5784-1_4 · Cited by 7
Effects of gemfibrozil on the activities of plasma lipolytic enzymes in normolipidemic subjects
Horsmans, Y., Desager, J. P., & Harvengt, C. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90187-9 · Cited by 6
Bianda, T., Zapf, J., Froesch, E. R., & Schmid, C. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00501.x · Cited by 6
Gylling, H. K., Relas, H., Miettinen, H. E., Radhakrishnan, R., & Miettinen, T. A. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05961-8 · Cited by 6
The genetic basis of lipoprotein disorders Introduction and overview
Breslow, J. L. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb01251.x · Cited by 6
Self-citationLe, N., Farkas-Epperson, M., Sweeney, M. E., Wilson, P. W. F., & Brown, W. V. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.09.022 · Cited by 5
Heidemann, B. E., Marais, A. D., Mulder, M. T., Visseren, F. L. J., van Lennep, J. E. R., Stroes, E. S. G., Riksen, N. P., van der Zee, L. C. V. V. –., Blackhurst, D., & Koopal, C. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.07.004 · Cited by 4
Postprandial lipaemia – the influence of diet and its link to coronary heart disease
Berry, S. (2005) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2005.00518.x · Cited by 7
ORLISTAT ABOLISHES POSTPRANDIAL LIPID PEAKING
Abejuela, Z. R., Macaballug, A. G., Sumpio, J. P., Zacarias, M., & MERCADO-ASIS, L. B. (2009) · Intern J Endocrinol Metab · Cited by 4
Weintraub, M. S., Grosskopf, I., Charach, G., Mor, R., Rubinstein, A., Wollman, Y., Judevices, R., & Iaina, A. (1995) · Metabolism · doi:10.1016/0026-0495(95)90137-x · Cited by 4
Self-citationChacra, A. P. M., Santos, R. D., Amâncio, R. F., Schreiber, R., Ramires, J. A. F., & Maranhão, R. C. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(03)00159-1 · Cited by 3
Pathology, Neurobiology, and Animal Models of Alzheimer's Disease
Sisodia, S. S., Price, D. D., Crain, B. J., & Troncoso, J. C. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch12 · Cited by 3
High Density Lipoprotein and Coronary Heart Disease: Lessons From Recent Intervention Trials
Bloomfield, H. E. (2000) · Preventive Cardiology · doi:10.1111/j.1520-037x.2000.80353.x · Cited by 3
Morishita, R., Gibbons, G. H., Kaneda, Y., Zhang, L., Ogihara, T., & Dzau, V. J. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750475 · Cited by 3
Effects of drugs on postprandial lipoprotein metabolism
Packard, C. J. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970075 · Cited by 3
Metabolismo posprandial en adultos mayores normales de nivel del mar
Garmendia, F., Pando, R., Torres, W., Valqui, W., Jamieson, C., & Blufstein, N. (2013) · Anales de la Facultad de Medicina · doi:10.15381/anales.v64i2.1441 · Cited by 2
Hemostatic Factors in Hypertriglyceridemic Men
Orth, M., Mayer, H., Halle, M., & Luley, C. H. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00007-9 · Cited by 2
Effects of Fibrates on the Altered Lipoprotein System in Hypertriglyceridemia
Eisenberg, S. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_56 · Cited by 1
Self-citationMETABOLISM OF SQUALENE IN TRIGLYCERIDE-RICH LIPOPROTEINS IN HUMANS
Relas, H. (2001) · Työväentutkimus Vuosikirja · Cited by 1
NON-CHOLESTEROL STEROLS IN SERUM, LIPOPROTEINS, AND RED CELLS
Ketomäki, A. (2004) · Cited by 1
Ketomäki, A. (2004) · Työväentutkimus Vuosikirja · Cited by 1
Impact of Meal Patterns on Caroteniod Absorption From Vegetables
Sapper, T. N. (2012) · Purdue e-Pubs (Purdue University System)
Modulation of Triglyceride Metabolism by Diet and Drugs
Pace, P., Knapp, R. D., Jones, P. H., Pownall, H. J., & Gotto, A. M. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_15
Gemfibrozil Improves Postprandial Hypertriglyceridemia in Patients with Isolated Low HDL
Kassem, H. S., Zantout, M. S., & Azar, S. T. (2011) · Lipid Insights · doi:10.4137/lpi.s5722
Drugs in the Management of Lipid Disorders
Bilheimer, D. W. (1991) · Springer eBooks · doi:10.1007/978-1-4612-3014-4_12
Relação da lipemia pós prandial com aterosclerose avaliada pela angiotomografia coronária
de Cardiologia, P. (2013)
Postprandial Lipoproteins and their Relationship to Atherosclerosis and Thrombosis
Cohn, J. S., & Davignon, J. (1996) · Medical science symposia series · doi:10.1007/978-94-009-0311-1_28
(2011) · The Internet Journal of Nutrition and Wellness · doi:10.5580/875
Catapano, A. L. (1995) · Medical science symposia series · doi:10.1007/978-94-011-0039-7_36
SCHWANDT, P., & Richter, W. O. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78426-2_14
Genetic lipid disorders, the APOE gene and Familial Dysbetalipoproteinemia
Heidemann, B. E. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1408
Rajaratnam, R. (2000) · Työväentutkimus Vuosikirja
Metadata
- Authors
- Weintraub, M. S., Eisenberg, S., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Hadassah Medical Center (IL)
- ORCID
- Breslow, J L
- Venue
- Journal of Clinical Investigation
- Published
- 1987-04-01
- Volume
- 79
- Issue
- 4
- Pages
- 1110-1119
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC424291
- OpenAlex
- W2156066000
- Cited by
- 261
- References
- 60
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 5 · 2020: 1 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 4 · 2012: 2
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pew Charitable Trusts
- American Heart Association
- National Institutes of Health
- National Institute on Aging (AG 04727)
- National Heart, Lung, and Blood Institute (HL 33714, HL32435)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- postprandial lipemia, lipoprotein metabolism, chylomicrons, type IV hyperlipoproteinemia, type III hyperlipoproteinemia, type IIa hyperlipoproteinemia, cholestyramine, gemfibrozil, lipoprotein lipase, hepatic lipase, atherosclerosis, atherogenic lipoproteins
- MeSH terms
- Cholestyramine Resin, Chylomicrons, Dietary Fats, Female, Humans, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type III, Hyperlipoproteinemia Type IV, Lipoproteins, Male, Pentanoic Acids, Triglycerides, Valerates, Vitamin A, Gemfibrozil
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review